Researchers from Arbor Biotechnologies have developed a versatile, specific, and high-efficiency genome-editing platform and showed the therapeutic potential of Cas12i in mammalian cells for the first time.
Jul 22, 2022
From human memory B cells, researchers at Merck & Co. have recently isolated over a hundred monoclonal antibodies that specifically target human metapneumovirus, a common cause of acute lower respiratory infection in children.
Jun 20, 2022
Researchers at Uppsala University have recently developed novel CAR T cells that outcompete conventional ones and induce advantageous immunological responses against solid tumors in mouse models.
May 18, 2022
Perturb-map is a new spatial functional genomics technology that unravels the mystery of tumor microenvironment and speeds up the discovery of new targets for better cancer therapies.
May 11, 2022
Researchers from Sloan Kettering Cancer Center recently designed a new type of CAR T cell that overcomes many hurdles of regular CAR T cell therapy and greatly enhances the anti-tumor efficacy of genetically engineered T cells.
Mar 17, 2022
Learn how investigators leverage the golden hamster model system to understand adaptive immune memory responses to SARS-CoV-2 and VOC.
Jan 17, 2022
Researchers from Oslo University Hospital recently found an appealing cancer target named TdT for short, providing new "eyes" of immune system to detect cancer cells.
Jan 09, 2022
Various vaccines based on different types of RNA are now under development to fight emerging SARS-CoV-2 variants, bringing new hopes for stopping the long-standing pandemic.
Sep 28, 2021